LAUREN WRIGHT: Open Payments
NPI 1386390318 · NEW BRAUNFELS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,026 in 54 payments from 14 companies in 2025. Trend: 2023 $801 · 2024 $956 · 2025 $1,026
Food & beverage: $1,026
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 13 | $255 |
| Boston Scientific Corporation | 8 | $180 |
| Amgen Inc. | 13 | $160 |
| Novo Nordisk Inc | 4 | $87 |
| Actelion Pharmaceuticals US, Inc. | 3 | $82 |
| Medtronic, Inc. | 3 | $62 |
| CVRx, Inc. | 2 | $42 |
| AtriCure, Inc. | 1 | $30 |
| E.R. Squibb & Sons, L.L.C. | 2 | $29 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $26 |
Products named: LEQVIO, Repatha, Ozempic, OPSYNVI, VENASEAL, LUX-Dx Insertable Cardiac Monitor, Barostim Neo System, General - Therapies.
Industry payments across TX — which companies pay providers there.
